Physician

Alvin F Wells, MD

According to 2025 Medicare claims, Alvin Wells, MD (NPI: 1134234859) practices rheumatology in the Crestview-Fort Walton Beach-Destin, FL market, with the plurality of this provider's patient population coming from Okaloosa, FL. This provider's primary affiliated billing organization is EMERALD COAST INFECTIOUS DISEASES MEDICAL GROUP, P.A. (NPI: 1720017882; TIN: 562483799) and primary practice location at 32541-0137. Wells is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Wells' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 258 traditional Medicare patients, billed 2,087 HCPCS/CPT codes, and received $53,659 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 4,512 prescription claims across 588 beneficiaries totaling $5,350,645 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2018 DME data shows 11 claims. Open Payments data shows 491 records totaling $526,514. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $600,668 to $53,659. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,619,817 to $5,350,645. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$300K$601K2015 Medicare payment: $600,668 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $550,598 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $94,163 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $79,598 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $61,103 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $44,909 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $33,857 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $26,590 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $25,281 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $53,659 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201554751,521$600,668
201647635,969$550,598
20174982,160$94,163
20184341,842$79,598
20193171,281$61,103
2020309669$44,909
2021311527$33,857
2022271460$26,590
2023238417$25,281
20242582,087$53,659

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.8M$7.5M2015 Drug cost: $1,619,817 (USD; Tot_Drug_Cst)2016 Drug cost: $1,603,860 (USD; Tot_Drug_Cst)2017 Drug cost: $3,054,231 (USD; Tot_Drug_Cst)2018 Drug cost: $3,809,550 (USD; Tot_Drug_Cst)2019 Drug cost: $2,845,395 (USD; Tot_Drug_Cst)2020 Drug cost: $3,698,677 (USD; Tot_Drug_Cst)2021 Drug cost: $5,162,908 (USD; Tot_Drug_Cst)2022 Drug cost: $7,545,062 (USD; Tot_Drug_Cst)2023 Drug cost: $5,947,717 (USD; Tot_Drug_Cst)2024 Drug cost: $5,350,645 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153802,321$1,619,817
20163502,536$1,603,860
20176334,837$3,054,231
20186774,987$3,809,550
20195773,862$2,845,395
20206234,773$3,698,677
20218185,419$5,162,908
20227535,063$7,545,062
20237165,288$5,947,717
20245884,512$5,350,645

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$716$1.4K2017 Medicare payment: $453 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,431 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R12$453
2018N/R11$1,431
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more6363$160
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more174195$61
99442Telephone medical discussion with physician, 11-20 minutes1819$39
99441Telephone medical discussion with physician, 5-10 minutes1919$18
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's204232$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab852,548$1,084,653
RinvoqUpadacitinib942,820$620,192
KevzaraSarilumab913,654$512,377
Humira(Cf)Adalimumab27762$347,941
Enbrel SureclickEtanercept391,092$288,951

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.474$367,362GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.17$159,152SANOFI US SERVICES INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alvin F. Wells, MD?

Tedicare shows public-source Medicare data for Alvin F. Wells, MD (NPI 1134234859), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alvin F. Wells, MD have ACO affiliation data?

Alvin F. Wells, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Alvin F. Wells, MD?

Alvin F. Wells, MD is linked to EMERALD COAST INFECTIOUS DISEASES MEDICAL GROUP, P.A. (billing NPI 1720017882) in the available physician profile data.

Does Alvin F. Wells, MD have Open Payments data?

Alvin F. Wells, MD has 491 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.